Table 5.

Molecular risk models A and B presented as NMIBC and MIBC clinical categories (See also Figure 4).

Model A
Low Risk (score 0–2)		Intermediate Risk (score 3–4)		High Risk (score 5–7)
43 (97.7%) NMIBC		22 (66.7%) NMIBC		1 (7.1%) NMIBC
1 (2.3%) MIBC		11 (33.3%) MIBC		13 (92.9%) MIBC
Model B
Low Risk (score 0–2)			High Risk (score 3–7)
43 (97.7%) NMIBC			23 (48.9%) NMIBC
1 (2.3%) MIBC			24 (51.1%) MIBC

NMIBC: Non-muscle invasive bladder cancer. MIBC: Muscle-invasive bladder cancer.